Brain NAD in Alzheimer's Disease
Recruiting
Observational Study
Alzheimer Disease (AD)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 65 – 80
- Sex
- Any
- Study type
- Observational
- Participants needed
- 20 (estimated)
- Sponsor
- Florida Atlantic University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this observational study is to learn about the levels of nicotinamide adenine dinucleotide (NAD) in the brains of people with Alzheimer's disease. The study aims to determine if brain NAD levels are lower in people with Alzheimer's disease compared with people of the same age group who do not have Alzheimer's disease.
Participants with or without Alzheimer's disease will have a brain …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Participants are able to come to the Florida Atlantic University Clinical Research Unit, are verbal and ambulatory.
* Age 65 to 80 included.
* People with Alzheimer's disease (AD): AD diagnosis established by the person's physician according to the following criteria: clinical…
Contacts